Number	Group
12	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
8	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
7	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

Advice on prevention and intervention in cases of violence and abuse

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? Yes
No care for children and young people

Commentary on the protection concept

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Training of employees on AMTS related topics

Availability of appropriate, topic-specific informational materials for patients on AMTS e.g. for chronic diseases, for high-risk drugs, for children

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Process description for an optimal medication process (e.g. drug anamnesis – prescription – patient information – drug delivery – drug application – documentation – therapy monitoring – result evaluation)

Umgang mit Medikamenten

15.09.2021

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
Zubereitung durch pharmazeutisches Personal

Electronic support for the supply of patients with drugs

Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)

Electronic documentation of the administration of drugs

Measures to minimise medication errors

Fallbesprechungen
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
4-Augen-Prinzip

Measures to ensure seamless drug therapy after discharge

Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
Aushändigung des Medikationsplans
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

Research & teaching

Job

FL03 - Student training (clinical traineeship / internship year)

Explanation

Famulatur jederzeit möglich, Praktisches Jahr nicht

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

Prof. Dr. Thomas Kallert (Medizinische Fakultäten der Technischen Universität Dresden, Karls-Universität Prag, Medizinische Universität Breslau)

Training

Training in other healing professions

HB01 - Nurse and health care worker (m/f)

Comment

Berufsfachschulen für Krankenpflege am Bezirkskrankenhaus Bayreuth und Bezirksklinikum Obermain, Standort Rehau als Kooperationspartner für die Krankenpflegeschulen der Kliniken Hochfranken und der Kliniken Fichtelgebirge, Hochfränkisches Bildungszentrum für Pflege- und Heilberufe der Diakonie Hof

HB17 - Auxiliary nurse (m/f)

Comment

Einjährige Ausbildung an der Berufsfachschule für Krankenpflegehilfe am Bezirkskrankenhaus Bayreuth

Hospital staff
Pharmaceutical personnel
- Number of pharmacists: 3
- Additional staff: 6
- Explanations: Versorgung durch die Apotheke am Bezirksklinikum Obermain

Service contact persons

Patient advocates

Karin Wolowiec

Patientenführsprecherin

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -599-0
Mail: ed.dem-obeg@uaher

Customer feedback management

Luisa Krause

Zentrales Qualitätsmanagement

Fohrenreuther Str. 48
95111 Rehau

Phone: 09382 -599-0
Mail: ed.dem-obeg@uaher

Steffi Vogler

Zentrales Qualitätsmanagement

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -599-0
Mail: ed.dem-obeg@uaher

Daniela Jost

Gesamtleitung Zentrales Qualitätsmanagement - Gesundheitseinrichtungen des Bezirks Oberfranken (GeBO)

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -599-0
Mail: ed.dem-obeg@uaher

Luisa Kaufmann

Zentrales Qualitätsmanagement

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -599-0
Mail: ed.dem-obeg@uaher

Quality management

Steffi Vogler

Zentrales Qualitätsmanagement

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -599-0
Mail: ed.dem-obeg@uaher

Hygiene officer

Prof. Dr. med. habil. Thomas Kallert

Leitender Ärztlicher Direktor - Gesundheitseinrichtungen des Bezirks Oberfranken (GeBO)

Fohrenreuther Str. 48
95111 Rehau

Phone: 0921 -283-3001
Mail: ed.dem-obeg@uaher

Responsible for drug therapy

Daniela Schneidenbach

Stellvertretende Chefärztin

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -599-0
Mail: ed.dem-obeg@uaher

Prof. Dr. med. habil. Thomas Kallert

Leitender Ärztlicher Direktor - Gesundheitseinrichtungen des Bezirks Oberfranken - GeBO

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -599-0
Mail: ed.dem-obeg@uaher

Accessibility Officer

Sascha Mainhardt

Öffentlichkeitsarbeit / Ansprechpartner für Menschen mit Beeinträchtigung

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -599-0
Mail: ed.dem-obeg@uaher

Company

General contact details of the hospital

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283-599-0
Mail: ed.dem-obeg@uaher

Nursing service management

Stephan Wörth

Bereichsleitung Pflege Haus 3 und 6 - Bezirksklinik Rehau

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -599-0
Mail: ed.dem-obeg@uaher

Wolfgang Schleicher

Gesamtstationsleitung Haus 2 - Bezirksklinik Rehau

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -599-0
Mail: ed.dem-obeg@uaher

Hartmut Schirmer

Gesamtstationsleitung Haus 1 - Bezirksklinik Rehau bis 31.05.2021

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -599-0
Mail: ed.dem-obeg@uaher

Franziska Egler

Gesamtstationsleitung Haus 1 - Bezirksklinik Rehau ab 01.06.2021

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -5990-
Mail: ed.dem-obeg@uaher

Head of administration

Katja Bittner

Vorstand - Gesundheitseinrichtungen des Bezirks Oberfranken (GeBO)

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -599-0
Mail: ed.dem-obeg@uaher

Torsten Keller

Standortleiter - Bezirkskrankenhaus Bayreuth / Bezirksklinik Rehau

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -599-0
Mail: ed.dem-obeg@uaher

Responsible for the quality report in the hospital management

Katja Bittner

Vorstand - Gesundheitseinrichtungen des Bezirks Oberfranken (GeBO)

Fohrenreuther Str. 48
95111 Rehau

Phone: 0921 -283-0
Mail: ed.dem-obeg@htueryab

Medical management

Dr. med. Torsten Brückner

Chefarzt - Bezirksklinik Rehau

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -599-0
Mail: ed.dem-obeg@uaher

Prof. Dr. med. habil. Thomas Kallert

Leitender Ärztlicher Direktor - Gesundheitseinrichtungen des Bezirks Oberfranken GeBO)

Fohrenreuther Str. 48
95111 Rehau

Phone: 09283 -599-0
Mail: ed.dem-obeg@uaher

Regional care obligation for psychiatry?

Yes

IK number

IK: 260940575

Location number

Location number: 772411000

Old location number: 772411000

Hospital portrait for download